What's new

Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 27, Status: Authorised

Apr 15, 2025 - 15:28
 0
Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Valdoxan, Agomelatine, Date of authorisation: 19/02/2009, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

Fees payable to the European Medicines Agency: General questions and answers

Next Article

EU mulls plan to let importers break Russian gas contracts without penalties

Related Posts

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 4, 2025  0

Union list of critical medicines: eXtended EudraVigilan...

Feb 14, 2025  0

Haematology Working Party

Haematology Working Party

Feb 9, 2025  0